A Th1-inducing Adenoviral Vaccine for Boosting Adoptively Transferred T Cells
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (1) , 211-217
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen ExpressionMolecular Therapy, 2009
- Yellow fever vaccine induces integrated multilineage and polyfunctional immune responsesJournal of Experimental Medicine, 2008
- Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyondVaccine, 2008
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative RegimensJournal of Clinical Oncology, 2008
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine, 2008
- Adenovirus-mediated gene transfer of pathogen-associated molecular patterns for cancer immunotherapyCancer Gene Therapy, 2008
- Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancerProceedings of the National Academy of Sciences, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppressionNature Medicine, 2008
- Failure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient MiceScience, 2000